S. Lopriore

Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA

F. Iannone, G. Lapadula, A. Notarnicola, 2015, Scandinavian journal of rheumatology.

Longterm Clinical Outcomes in 420 Patients with Psoriatic Arthritis Taking Anti-tumor Necrosis Factor Drugs in Real-world Settings

G. Lopalco, F. Iannone, L. Cantarini, 2016, The Journal of Rheumatology.

Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register.

F. Salaffi, S. Gasparini, P. Sarzi-Puttini, 2014, Joint, bone, spine : revue du rhumatisme.

Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases

Matthew L. Thomas, G. Shaddick, R. Charlton, 2020, The Journal of Rheumatology.